E85.2

Clinical Causes: Genetic mutations inherited from family members Presence of abnormal amyloidogenic proteins due to specific gene variations Familial patterns observed through family history Inheritance often follows an autosomal dominant pattern, meaning only one copy of the altered gene can cause the disorder

Key Symptoms: Progressive weakness and fatigue Swelling in affected organs or tissues Carpal tunnel syndrome or nerve entrapment symptoms Heart-related symptoms such as shortness of breath, irregular heartbeat, or swelling of the legs Kidney problems, including proteinuria and potential kidney failure Liver enlargement and related discomfort Gastrointestinal issues like malabsorption, diarrhea, or weight loss Signs of neurological involvement, such as peripheral neuropathy

Diagnosis Path: Diagnosing heredofamilial amyloidosis involves a combination of clinical assessment and specialized tests. Healthcare providers may perform blood and urine tests to detect abnormal proteins, and biopsies of affected tissues can confirm amyloid deposits using special staining techniques. Genetic testing plays a significant role in identifying specific mutations associated with the hereditary form of amyloidosis. Imaging studies, such as echocardiograms or MRI scans, help evaluate organ involvement, especially in the heart and liver. Early diagnosis is crucial for managing symptoms and preventing severe complications.

Treatment Protocols: Medications to reduce amyloid protein production or prevent its deposition Supportive therapies tailored to affected organs, such as diuretics for heart failure or dialysis for kidney failure Gene-targeted therapies and emerging treatments in experimental stages Organ transplantation in severe cases, such as heart or liver transplants Regular monitoring of organ function to adapt treatment plans accordingly Genetic counseling for affected families to understand inheritance patterns and risks